Treatment of inflammatory bowel disease

US7855226B2 · kind B2 · utility

Assignee

• Allergan, Inc. · US

Inventors

• Yariv Donde · Dana Point, US
• Jeremiah H. Nguyen · La Puente, US
• Karen M. Kedzie · Atascadero, US
• Daniel W. Gil · Newport Beach, US
• John E. Donello · Dana Point, US
• Wha-Bin Im · Irvine, US

Key dates

• Filing date: Mar 17, 2005
• Grant date: Dec 21, 2010
• Expiry date: Jul 29, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed herein is a method comprising administering a compound to a mammal suffering from an inflammatory bowel disease for the treatment of said disease, said compound having a structure according to Formula Iwherein X, Y, B, R2, R3, R4, R5, R6 and n have the meanings found herein.